FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

BDX

Becton DickinsonNYSE · Health Care Equipment · Health Care
Previous close
181.85
Change
−4.07 / −2.19%
FinDog View
Neutral
52-Week Range
140.11 – 213.08
P/E (TTM)
52.6
Forward P/E
12.4
Based on consensus earnings for the next 12 months
Market Cap
$49.5B
1M
−0.13%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.7M / 1.6M
1.07× average

Price History

Closing price · USD1M6M1Y5Y
100150200250300FY26 Q3 EarningsFY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 Earnings2021-092022-122024-032025-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 56.71M6M1Y5Y
525456582026-082026-082026-092026-092026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q3
Quarter ended 2026-06
2026-08-06$5.0B3.23 / 3.17−0.12%Read analysis →
FY2026 Q2
Quarter ended 2026-03
2026-04-02$4.7B2.90 / 2.80+0.52%Pending
FY2026 Q1
Quarter ended 2025-12
2026-02-09—— / —−17.22%Pending
FY2025 Q4
Quarter ended 2025-09
2025-10-15—— / —−0.80%Pending
FY2025 Q3
Quarter ended 2025-06
2025-08-07—— / —+3.10%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 88 of its 5-year rangeExpensive
5-year range 25.9 – 56.7 · Median 39.2
Last 4 quarters: $2.5B in buybacks + $1.2B in dividends, 7.41% of market cap combined
P/E (TTM)
52.6
P/B
2.0
P/S
2.4
Dividend Yield
1.59%
Earnings Reaction
Over the last 5 reports, the stock moved ±4.4% on average on the first trading day after, rising 2 times
Most recent −0.12%
Volatility & Correlation
1-year beta 0.39 · Correlation with S&P 500 0.16Low beta
Annualized volatility 31% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 6 · $1.4MNet selling $1.4M
  • 08-26Feld MichaelEVP, Chief Revenue OfficerSell$0.03M165 shares · Avg price 188.49
  • 08-13Polen Thomas E JrChairman, CEO and PresidentSell$0.77M4,152 shares · Avg price 185.00
  • 08-11Goette RolandEVP and President, EMEASell$0.44M2,438 shares · Avg price 180.84
  • 07-27Feld MichaelEVP, Chief Revenue OfficerSell$0.01M75 shares · Avg price 157.13
  • 06-26Feld MichaelEVP, Chief Revenue OfficerSell$0.01M75 shares · Avg price 152.80
  • 06-24Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmSell$0.16M1,100 shares · Avg price 145.66
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q34.98+5.4%46.5%0.660.38—1.37
FY2026 Q24.71+5.2%45.7%0.09-0.31—-1.11
FY2026 Q15.25+1.6%45.9%0.550.380.551.34
FY2025 Q47.47+37.3%48.1%1.000.49—1.71
FY2025 Q34.73−5.3%47.3%0.740.57—2.00
FY2025 Q24.48−11.2%41.5%0.380.31—1.07
FY2025 Q15.17+9.8%43.2%0.450.300.591.04
FY2024 Q45.44+6.9%45.7%0.620.40—1.37
FY2024 Q34.99+2.3%46.2%0.600.49—1.68
FY2024 Q25.05+4.6%45.7%0.730.54—1.85
FY2024 Q14.71+2.6%43.1%0.440.28—0.96
FY2023 Q45.09+6.8%33.5%0.350.11—0.35

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
BDXBecton Dickinson$49.5B52.6+5.4%46.5%−0.13%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare